Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Bioventus (BVS) Receivables - Net (2020 - 2025)

Bioventus' Receivables - Net history spans 6 years, with the latest figure at $131.2 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 2.99% year-over-year to $131.2 million; the TTM value through Dec 2025 reached $131.2 million, up 2.99%, while the annual FY2025 figure was $131.2 million, 2.99% up from the prior year.
  • Receivables - Net reached $131.2 million in Q4 2025 per BVS's latest filing, up from $130.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $143.0 million in Q3 2022 to a low of $89.5 million in Q2 2021.
  • Average Receivables - Net over 5 years is $124.0 million, with a median of $125.7 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: soared 40.17% in 2022, then decreased 18.21% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $125.0 million in 2021, then grew by 9.07% to $136.3 million in 2022, then fell by 6.81% to $127.0 million in 2023, then grew by 0.3% to $127.4 million in 2024, then grew by 2.99% to $131.2 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Receivables - Net are $131.2 million (Q4 2025), $130.4 million (Q3 2025), and $135.3 million (Q2 2025).